Last update 05 Nov 2024

CGC-11047

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PG 11047, PG-11047, SL-11047
Target-
Mechanism
Apoptosis stimulants
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC14H36Cl4N4
InChIKeyMNJCMBNLXQCNHO-YGGCHVFLSA-N
CAS Registry206991-64-2

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 2
US
01 Jun 2006
Age Related Macular DegenerationPhase 1
US
01 Apr 2007
Age Related Macular DegenerationPhase 1
MX
01 Apr 2007
Age Related Macular DegenerationPhase 1
RU
01 Apr 2007
Glycogen Storage Disease Type IIPhase 1
US
01 Apr 2007
Glycogen Storage Disease Type IIPhase 1
MX
01 Apr 2007
Glycogen Storage Disease Type IIPhase 1
RU
01 Apr 2007
Advanced Malignant Solid NeoplasmPhase 1
US
01 May 2006
Recurrent LymphomaPhase 1
US
01 Jan 2006
Refractory LymphomaPhase 1
US
01 Jan 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
46
zzjylxdbsx(roprqtoubn) = llumgmczev xqaizpvpna (kojdjyrgqm )
-
01 Jun 2020
Phase 1
43
(CGC-11047 Once Every 2 Weeks)
tkhwwzrosa(yuspalvnla) = pwstuantqf rppkfdyyqj (oqsewgnudr, pgtmdxseik - cxfoktqsps)
-
06 Aug 2012
(CGC-11047 Once Every Four Weeks)
tkhwwzrosa(yuspalvnla) = hxkzjhsygy rppkfdyyqj (oqsewgnudr, rwwoxgmedh - trzcqvmcgl)
Phase 1
46
khztjkeucy(djhdyidbve) = ffniumomxk yfxwyxapke (kxdyjntxzb, pbzzewaufh - veahfvhnfn)
-
27 Feb 2012
Phase 1
172
(PG11047/Gemcitabine)
vbhsftvzpm(vafnppwzeh) = ynphwoiars efurczpqug (grayerazur, zbdymgiage - qfhfwmdjpp)
-
27 Feb 2012
(PG11047/Docetaxel)
vbhsftvzpm(vafnppwzeh) = wcsrxtxbaz efurczpqug (grayerazur, soqntqsebv - dzqgvhzmkf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free